LACE Index for Readmission
The LACE Index estimates a patient’s risk of unplanned 30‑day hospital readmission using length of stay, acuity, comorbidities, and emergency department visits.
Indications for Use
Used at discharge or early during hospitalization to flag adults at higher risk for 30‑day unplanned readmission so transitional care can be targeted. Appropriate in general medical inpatients; performance is moderate (C‑statistic typically 0.65–0.72 in validation studies 1 [Level II evidence]). AMI cohorts show similar moderate discrimination around 0.71–0.78 2 [Level II evidence]. Not reliable in oncology where accuracy is poor (AUC 0.45) 3 [Level II evidence].
Insights & Cautions
Identifies readmission risk but offers only moderate discrimination and varies by population. In a systematic review of 26 models using administrative data, typical C‑statistics were 0.55–0.65 1 [Level II evidence]. In oncology patients, performance was poor (AUC 0.45) 2 [Level II evidence]. AMI-specific validation showed moderate accuracy (C 0.71) 3 [Level II evidence]. Lacks social/functional predictors, is sensitive to case mix, and may misestimate preventable readmissions.